Influence of Diagnostic Errors on the Prognosis of Acute Pulmonary Embolism
NCT ID: NCT03101384
Last Updated: 2017-06-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
302 participants
OBSERVATIONAL
2017-04-11
2019-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Validation of Different Risk Assessment Strategies in Normotensive Pulmonary Embolism
NCT02843243
Prognostication in Acute Pulmonary Embolism
NCT02733198
Age-adjusted D-dimer Cut-off Levels to Rule Out Pulmonary Embolism
NCT01134068
The Role of Endothelial Function Test in Risk Stratification for Early and Late Complications After Pulmonary Embolism
NCT03149471
Low-dose CT Angiography in the Detection of Acute Pulmonary Embolism: Validation in an Obese Population
NCT04018014
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient with a diagnostic error
Defined by one of :
1. Absence of prescribed test included in an accepted pulmonary diagnosis algorithm in the next 48h00 after the firts contact with a physician
2. Absence of prescribed test included in an accepted pulmonary diagnosis algorithm by the first contacted physician but the diagnostic is done before 48h00 because the patient went at the emergency room on his own initiative.
3. More than one doctor consulted before the diagnostic of pulmonary embolism (excluding the emergency physician if the patient was referred by the 1st contact doctor)
Diagnostic error
There is no intervention in our study. Patient will be managed with usual care. We will divide patients in the 2 groups according to the presence of diagnostic error.
Patient without a diagnostic error
Any patient that did not meet the criteria to define the diagnostic error
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Diagnostic error
There is no intervention in our study. Patient will be managed with usual care. We will divide patients in the 2 groups according to the presence of diagnostic error.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Episode of symptomatic acute pulmonary embolism objectively proven
Exclusion Criteria
* Patient chronically receiving therapeutic anticoagulation
* Pulmonary embolism complicating a current hospitalisation for another medical reason
* Asymptomatic pulmonary embolism
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Georges Pompidou Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Guy Meyer
Professeur des Universités
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guy Meyer, Pr
Role: PRINCIPAL_INVESTIGATOR
Hôpital Européen Georges Pompidou, AP-HP
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital européen Georges Pompidou
Paris, Île-de-France Region, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
N° ID RCB : 2017-A00433-50
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.